In this issue:
Member & Local News
- Province, University of Manitoba, GlaxoSmithKline Establish Endowed Research Chair to Study Infectious Disease
- Barda Exercises Options with Cangene Worth US$61 Million Under Botulism Antitoxin Supply Contract
- Manitoba will Implement First-in-Canada, Groundbreaking Cancer Wait-Time Strategy
- Valeant and GlaxoSmithKline Announce U.S. FDA Approval of Potiga
- Study Seeks to Ease Breast-Cancer Drug Risk
Life Science in the News
- Biofuels not to Blame for High Food Prices
- LifeScience Alley Board of Directors Elects New Officers
- The Future of Food Needs to Include Biotech Crops
- Lasers Built with Living Cells
- There’s a Role for Biomass Energy in Ontario
Countdown to BIO Convention!
Interested in joining the LSAM Board of Directors?
Access the newsletter here.
About the Life Science Association of Manitoba (LSAM):
LSAM represents all those involved in the Life Science Sector in Manitoba. The Life Science Sector focuses on the use of innovative biological tools and products, the creation of wealth and sustainability in the production of medical treatments, diagnostics, more-nutritional foods, energy, chemicals, and materials, while improving the quality of the environment.
The Life Science sector is a key to economic growth within the Province of Manitoba and is currently estimated to contribute more than 7% of the province’s GDP. In addition to generating value on its own, the Life Science sector is helping to grow and sustain competitiveness in ailing and traditional sectors of the economy, through the application of new and innovative products and processes.
To find out more about LSAM visit its website here